molar ratio of LnCl3 and ligand in water followed by addition
of KOH to adjust the pH to 7. The reaction mixtures were
briefly heated to 70 ◦C and then stirred at rt overnight. The
1,4,7,10-Tetraazacyclododecane-4,7,10-triacetic-1-{methyl
[(4-nitrophenyl)methyl)]phosphinic acid} (6)
The H3DO3A·H2SO4 (5·H2SO4) (6.4 g, 14.4 mmol) was dissolved
in azeotropic HCl (70 ml) and phosphinic acid 4 (11.6 g,
57.6 mmol) was added. The suspension was heated to 80 ◦C
and paraformaldehyde (3.45 g, 115 mmol) was added in small
portions over 6 h. The mixture was then heated at 110 ◦C for 2
d. Subsequently, it was filtered and the filtrate was evaporated
to dryness in vacuum and co-distilled with water (3 × 150 ml) to
remove excess HCl. The residue was dissolved in water (20 ml)
and poured on top of a Dowex 50 column (3 × 15 cm, H+-form).
The column was washed with water (500 ml), 50% aqueous
EtOH (1500 ml) and aqueous ammonia (5%, 200 ml). The crude
product was eluted with ammonia. The fraction was evaporated
to dryness and the residue was dissolved in a small amount
of water (5 ml). It was chromatographed on Amberlite CG50
column (5 × 20 cm, H+-form) with water elution. Fractions
containing the pure (1H and 31P NMR) product 6 were combined
and evaporated to dryness. The residue was dissolved in water
(5 ml) and the solution was dropped into stirred anhydrous
EtOH (500 ml). The suspension was stirred overnight, filtered
and washed with EtOH (30 ml) and diethylether (30 ml). The
light yellow product was dried at rt in air overnight to yield 4.7 g
(53%) of 6·3H2O. dH (400 MHz; 90 ◦C; tBuOH); 3.04–3.19 (20 H,
m, ring CH2 + CH2–P–CH2); 3.46 (2 H, br s, CH2COOH); 3.63
(4 H, br s, CH2COOH); 7.38 (2 H, m, aryl); 8.08 (2 H, m, aryl); dc
(100.6 MHz; 90 ◦C; tBuOH) 36.6 (1 C, d, JPC 79.4); 46.1 (2 C,br
s); 46.8 (2 C, br s); 47.8 (2 C, br s); 47.9 (2 C, br s); 48.5 (1 C, d, JCP
88.5); 51.3 (1 C, br s); 53.4 (2 C, br s); 120.975 (2 C, s); 127.9 (2 C,
d, JCP 4.2); 140.2 (1 C, d, JCP 8); 143.3 (1 C, d, JCP 3) 168.3 (2 C, br
s); 170.7 (1 C, br s); dP (161.9 MHz; 90 ◦C; ext. 85% H3PO4) 33.8
(br s); m / z (ESI/MS) 560.2 (M + H)+, C22H35N5O10P requires
560.5; 581.1 (M + Na)+, C22H34N5NaO10P requires 581.5; Found:
C, 41.96; H, 7.20; N, 10.76. Calc. for C22H34N5O10P·3H2O: C,
43.07; H, 6.57; N, 11.41%
1
complexes for H and 31P NMR spectroscopy were isolated in
the solid state; the slight excess of LnCl3·xH2O was added to the
solution of DO3APABn followed by pH adjustment to 7. After
the pH stabilization the mixture was heated at 50 ◦C overnight.
The complexes were purified on Amberlite CG50 with water
elution. All solutions were tested negative in the presence of free
lanthanide(III) ions by using xylenol orange as an indicator (in
0.1 M NaAc/HAc buffer solution, pH 5.2). The concentration
of lanthanide(III) ions in complex solutions was determined by
1
measuring the H NMR shift caused by the change of bulk
magnetic susceptibility.24
1H relaxometry
The water proton 1/T1 longitudinal relaxation rates (10 MHz,
25 and 37 ◦C) were measured with a Stelar Spinmaster Spec-
trometer FFC relaxometer (Mede, Pv, Italy; installed at the
Laboratorio Integrato di Metodologie Avanzate, Bioindustry
Park del Canavese (Colleretto Giacosa, Torino, Italy)) on 0.8–
1.2 mM aqueous solution of the complex. The 1H spin–lattice
relaxation times T1 were acquired by the standard inversion
recovery method with typical 90◦ pulse width of 3.5 ls, 16
experiments of 4 scans. The reproducibility of the T1 data was
5%. The temperature was controlled with a Stelar VTC-91 air-
flow heater equipped with a copper–constantan thermocouple
(uncertainty of 0.1 ◦C). The 1/T1 NMRD profiles of water
protons were measured over a continuum of magnetic field
strength from 0.00024 to 0.70 T (corresponding to 0.01–30 MHz
proton Larmor frequency) on the fast field-cycling relaxometer.
The relaxometer operates under complete computer control
with an absolute uncertainty in the 1/T1 values of 1%. The
concentration of the aqueous solutions of the complexes utilized
for the measurements was in the range 1.0–5.0 mM.
17O relaxation measurements
1,4,7,10-Tetraazacyclododecane-4,7,10-triacetic-1-{methyl
[(4-aminophenyl)methyl)]phosphinic acid} DO3APABn
Variable-temperature 17O NMR relaxation measurement were
performed at 500 MHz Bruker AM-500 (11.7 T, 67.8 MHz)
spectrometer and Bruker VT-1000 temperature control unit was
used to stabilize the temperature. The complex solutions were
enriched by addition of H217O (2.6% Yeda, Israel) to overall
ca. 0.1% 17O concentration. Transversal 17O NMR relaxation
rates were measured by standard Carr–Purcell–Meiboom–Gill
spin echo pulse sequence; 8–10 increments on d2 exponentially
sampled; at = 0.2; d1 = 0.2 (d2 is delay time corresponding to the
time of echo; at is acquisition time; d1 is repetition time). These
data were compared with those calculated from the line-width
at half-height. The deviations were lower that 5%. These NMR
spectra were conducted without frequency lock.
Macrocycle 6·3H2O (2.5 g, 4.1 mmol) was dissolved in water (150
ml). Several drops of azeotropic HCl and 10% Pd/C (0.5 g) were
added. The flask was filled with hydrogen, and the nitroderivative
was hydrogenated at rt and 1 atm for 2 d. The catalyst was
filtered off and the filtrate evaporated to dryness in vacuum.
Chromatography on Amberlite CG50 as for 6 gave fractions of
pure ligand which were combined and water was removed in
vacuum. The residue was dissolved in water (3 ml) and dropped
into stirred anhydrous EtOH (500 ml). The suspension was
stirred overnight, filtered and washed with EtOH (30 ml) and
diethylether (30 ml). The product was dried in air at rt overnight
to yield 2.2 g (91%) of DO3APABn·3H2O. dH (400 MHz: D2O;
◦
90 C; tBuOH) 2.96 (2 H, d, JPH 16, H16), 3.01 (2 H, d, H13,
Data evaluation
JPH 4), 3.05 (4 H, br s, H6), 3.18 (4 H, br m, H3), 3.20 (4 H,
br m, H2), 3.22 (4 H, br m, H5), 3.45 (2 H, br m, H15), 3.65
(4 H, br m, H14), 7.24 (2 H, m, H18), 7.32 (2 H, m, H17); dC
1
The treatment of the H NMR T1 and17O NMR T2 data were
performed with Micromath Scientist fitting routines based on
◦
(100.6 MHz: D2O; 90 C; tBuOH) 39.1 (1 C, d, C16, JCP 73.4)
SBM equations (refer to supplementary information†).1,19
49.1 (2 C, s, C6); 49.6 (2 C, s, C2); 51 (1 C, d, C13, JCP 96.6);
51.2 (2 C, s, C3); 51.4 (2 C, s, C5) 54.4 (1 C, s, 15); 56.7 (2 C, s,
C14); 123.3 (2 C, d, 19, JCP 2.7); 129.1 (1 C, s, C20); 131.6 (2
C, d, C18, JCP 5.3) 135.6 (1 C, d, C17, JCP 7.2); dP (161.9 MHz;
D2O; 90 ◦C; ext. 85% H3PO4) 32.5 (br s); m / z (ESI/MS) 552.2
(M + Na)+, C22H36N5NaO8P requires 552.0; 530.3 (M + H)+,
C22H36N5O8P requires 530.5; 359.3 (M − P(O)(OH)–NO2Bn)+,
C15H27N4O6 requires 359.4; Found: C, 45.70; H, 7.19; N, 11.67.
Calc. for C22H36N5O8P·3H2O: C, 45.28; H, 7.25; H, 12.00%
Acknowledgements
We thank Bracco SpA for a kind gift of H3DO3A·H2SO4.
Support from the Grant Agency of Czech Republic (No.
203/020493 and No. 203/03/0168), the Ministry of Edu-
cation of Czech Republic (CZEJ07/98:1491000111), GAUK
(423/2004/B-CH/PrF) and MUIR (FIRB) is acknowledged.
The work was done in frame of COST D18 Action.
Complex preparation
Lanthanide(III) complexes of DO3APABn for 17O and 1H NMR
relaxometric measurements were prepared by mixing a 1 : 1.1
References
1 (a) The Chemistry of Contrast Agents in Medical Magnetic Resonance
Imaging, ed. A. E. Merbach and E. To´th, Wiley, Chichester, UK,
´
1 1 6
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 1 1 2 – 1 1 7